Fresenius Medical Care study links GLP-1 use to lower mortality in dialysis patients
FMS•A study of about 5,000 dialysis patients linked GLP-1 receptor agonist use to significantly lower mortality and fewer hospitalizations. Fresenius Medical Care will present kidney care research at ASN Kidney Week in Denver, Oct. 21–25, 2026.
1. Research presentations
Fresenius Medical Care will present kidney care research at ASN Kidney Week in Denver, Oct. 21–25, 2026. A study of about 5,000 dialysis patients linked GLP-1 receptor agonist use to significantly lower mortality and fewer hospitalizations; separate U.S. studies examined high-volume hemodiafiltration and integrated continuous kidney replacement therapy.
